Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 03. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8935  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178683  
   
Clinical Characteristics and Outcomes of Immune Checkpoint Inhibitor Associated Renal Toxicities: A Retrospective Pan-Cancer Cohort Study.
Clin Ther
Trivedi C, Contini J, Adams M, Steuer RZ, Jain SK, Chu JJ, Gupta SR, Petruzzelli C, Malani K, Park W, Constantinou M, Lagos G, Min M, Hadfield MJ.
PMID: 42230259 [PubMed - as supplied by publisher]


Inflammation-Driven Transcriptional Reprogramming in Prostate Cancer: Convergence of NFκB, JAK/STAT3, and Epigenetic Remodeling in Castration-Resistant Disease.
Cancer Lett
Krishna M, Garg P, Horne D, Salgia R, Singhal SS.
PMID: 42229824 [PubMed - as supplied by publisher]


Beyond GnRH analogues: The Renaissance of Estrogens in Prostate Cancer Management.
Fr J Urol
Matthys M, Klein C, Roumeguère T, Bladou F, Robert G, Tombal B.
PMID: 42229758 [PubMed - as supplied by publisher]


Reply: UGN-102 for Recurrent Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A 24-Month Duration of Response Results from the Phase 3 ENVISION Trial.
J Urol
Prasad S.
PMID: 42229364 [PubMed - as supplied by publisher]


Targeting mitochondrial metabolism in renal cell carcinoma with melatonin: Preclinical evidence and clinical perspectives.
Tissue Cell
Noroozi-Karimabad M, Alimohammadi M, Mafi A, Hedayati N, Razavi FT, Cho WC, Mohammad-Sadeghipour M, Farahani N, Entezari M, Daneshi S, Hushmandi K, Taheriazam A, Hashemi M.
PMID: 42229285 [PubMed - as supplied by publisher]


Magnetic resonance imaging-guided radiotherapy for prostate cancer: A systematic review of the literature.
Cancer Radiother
Adoum SL, Baty M, Masson I, Le Guévelou J, Lafond C, Créhange G, Chapet O, Pasquier D, Riou O, Truc G, Salem N, Simon JM, de Crevoisier R.
PMID: 42229011 [PubMed - as supplied by publisher]


Impact of radiotherapy timing on survival and radiotoxicity outcomes in localized prostate cancer: a retrospective cohort study.
Radiol Med
Oliveira-Sousa R, Castro C, Carriço ÍR, Leite-Silva P, Macedo-Silva C, Bravo I, Santos J, Jerónimo C, Miranda-Gonçalves V.
PMID: 42228040 [PubMed - as supplied by publisher]


Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.
Clin Cancer Res
Smoragiewicz M, Bernard-Tessier A, Linch M, Shen J, Shore ND, Parikh O, Chi KN, Sokolova AO, Culine S, McKean M, Gleave M, Devitt ME, Zhi E, Gong J, Landrette S, Colasanto M, Patel V, Gao X.
PMID: 42227954 [PubMed - as supplied by publisher]


One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study.
Radiology
de Bie KCC, Cornud FC, Walser EM, van Riel LAMJG, Regusci S, Martins Favre M, Zimmer RE, Galiano M, Manenti G, Micillo A, Oddens JR.
PMID: 42227864 [PubMed - in process]


Diagnostic accuracy of contrast-enhanced ultrasound for detecting renal cancer: a systematic review and meta-analysis.
Med Ultrason
Xu R, He Y, Xie X, Chen G.
PMID: 42227142 [PubMed - as supplied by publisher]


A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.
Nanomedicine (Lond)
Narayan A, Leibrandt RC, Lee JS, Dall'Era MA, Whitson JM, Chandrasekar T, Braun A, Mossanen M, Li H, Lara PN Jr, Lam KS, Pan CX, Parikh M.
PMID: 42226594 [PubMed - as supplied by publisher]


Study adds new evidence on use of salvage focal therapy for radio-recurrent prostate cancer.
Cancer
Lawrence L.
PMID: 42226545 [PubMed - in process]


Impact of Absolute PSA Value and Relative PSA Response Rate on Overall Survival in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Int J Urol
Suzuki T, Fukuda T, Nishizaki K, Fukui K, Yoshioka S, Kaizuka Y, Nagasawa S, Togo Y, Motoki Y, Tanaka W, Ueda Y.
PMID: 42226505 [PubMed - in process]


Development and validation of a machine learning model for predicting distant metastasis in patients with renal cell carcinoma: a population-based study.
World J Surg Oncol
Cheng C, Peng X, Qiu R, Ma H, Gui M, Shi R.
PMID: 42226290 [PubMed - as supplied by publisher]


MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.
Eur Urol Oncol
Boschheidgen M, Al-Monajjed R, Schlemmer HP, Krilaviciute A, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Lakes J, Radtke JP, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Benner A, Antoch G, Becker N, Kaaks R, Albers P, Schimmöller L.
PMID: 42225542 [PubMed - as supplied by publisher]


Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
Semin Nucl Med
Sadeghpour S, Saidi B, Sahafi P, Maleki F, Ranjbar S, Ghorbani M, Ghadiri Hakim H, Aghaee A, Fanti S, Beheshti M, Askari E.
PMID: 42225513 [PubMed - as supplied by publisher]


Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
DeWeese TL, Manzanera A, Sylvester J, Wheeler T, Schroeder T, Gejerman G, Chesnut G, Facelle TM, Garzotto MG, Pieczonka C, Gandhi NM, Sukin S, Liss MA, Tutrone R, Mehlhaff B, Savage SJ, Goody M, Vogt J, Rao S, Polanco MLS, Barone F, Nichols WG, Tak PP, PrTK03 study team.
PMID: 42225101 [PubMed - indexed for MEDLINE]


Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
JAMA Netw Open
Zhang W, Wu H, Wang L, Xu H, Lin T, Tan P, Zhang P, Zheng X.
PMID: 42223943 [PubMed - indexed for MEDLINE]


Robotic-assisted radical prostatectomy using the Toumai system: initial single-center experience in Morocco.
J Robot Surg
Et-Touzani R, Aoid I, Zemrag J, Tibari Y, Ej-Jennane A, Bouab A, Faik H, Labyad A, Laraqui L, Deffar N, Touzani A, Ouzzane A.
PMID: 42223781 [PubMed - indexed for MEDLINE]


Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity.
J Robot Surg
Zorzi F, Amodeo A, Moretto S, Ingels A, Crestani A, Di Gianfrancesco L, Giannarini G, Tulone G, Simonato FA, Liguori G, Panthier F, Pandolfo SD, Contieri R, Perdonà S, Simonato A, Porreca A, Pavan N, Claps F.
PMID: 42223755 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 178683    Seite 1 von 8935  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1